BioMarin to Participate in Two Upcoming Virtual Investor Conferences
BioMarin Pharmaceutical (NASDAQ: BMRN) announces participation in two upcoming virtual investor conferences, scheduled for December 2021. An audio webcast will be available live, and archived presentations can be accessed on their website for a limited time. BioMarin specializes in innovative therapies for rare genetic diseases, boasting a diverse portfolio of commercial and clinical products. For more details, visit their website.
- None.
- None.
SAN RAFAEL, Calif., Nov. 29, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in two upcoming virtual investor conferences. An audio webcast of the presentations will be available live. You can access the webcasts at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases. The Company's portfolio consists of several commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com. Information on such website is not incorporated by reference into this press release.
Contacts: | |
Investors | Media |
Traci McCarty | Debra Charlesworth |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (415) 455-7451 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-two-upcoming-virtual-investor-conferences-301431719.html
SOURCE BioMarin Pharmaceutical Inc.
FAQ
When will BioMarin participate in virtual investor conferences?
How can I access the webcasts for BioMarin's investor conferences?
What is the focus of BioMarin as a biotechnology company?
What is the stock symbol for BioMarin Pharmaceutical?
